Investigating the various predictive values of POLE/POLD1 mutations for response to immune checkpoint inhibitors (ICIs) in different solid tumors. Awareness and utilization of tumor mutation burden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback